Search Results - Khattak, Adnan

Etiology of white pupillary reflex in pediatric age group by Israr, Muhammad, Zahir, Khalil Khan, Khattak, Adnan, Khattak, Irfan Ullah, Gul, Nazli

Get full text Get full text Get full text

Eftilagimod alpha, a soluble lymphocyte activation gene-3 (LAG-3) protein plus pembrolizumab in patients with metastatic melanoma by Atkinson, Victoria, Khattak, Adnan, Haydon, Andrew, Eastgate, Melissa, Roy, Amitesh, Prithviraj, Prashanth, Mueller, Christian, Brignone, Chrystelle, Triebel, Frederic

Get full text Get full text Get full text

Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGF-β and PD-L1, in Patients with Esophageal Adenocarcinoma: Results from a Phase 1 Cohort by Tan, Benjamin, Khattak, Adnan, Felip, Enriqueta, Kelly, Karen, Rich, Patricia, Wang, Ding, Helwig, Christoph, Dussault, Isabelle, Ojalvo, Laureen S., Isambert, Nicolas

Get full text Get full text Get full text

Molecular testing and treatment patterns for patients with advanced non-small cell lung cancer: PIvOTAL observational study by Lee, Dae Ho, Tsao, Ming-Sound, Kambartel, Karl-Otto, Isobe, Hiroshi, Huang, Ming-Shyan, Barrios, Carlos H., Khattak, Adnan, de Marinis, Filippo, Kothari, Smita, Arunachalam, Ashwini, Cao, Xiting, Burke, Thomas, Valladares, Amparo, de Castro, Javier

Get full text Get full text Get full text

Impact of the COVID-19 Pandemic on Cancer Care: A Global Collaborative Study by Jazieh, Abdul Rahman, Akbulut, Hakan, Curigliano, Giuseppe, Rogado, Alvaro, Alsharm, Abdullah Ali, Razis, Evangelia D., Mula-Hussain, Layth, Errihani, Hassan, Khattak, Adnan, De Guzman, Roselle B., Mathias, Clarissa, Alkaiyat, Mohammad Omar Farouq, Jradi, Hoda, Rolfo, Christian

Get full text Get full text Get full text

Association Between Immune-Related Adverse Events and Recurrence-Free Survival Among Patients With Stage III Melanoma Randomized to Receive Pembrolizumab or Placebo: A Secondary An... by Eggermont, Alexander M. M., Kicinski, Michal, Blank, Christian U., Mandala, Mario, Long, Georgina V., Atkinson, Victoria, Dalle, Stéphane, Haydon, Andrew, Khattak, Adnan, Carlino, Matteo S., Sandhu, Shahneen, Larkin, James, Puig, Susana, Ascierto, Paolo A., Rutkowski, Piotr, Schadendorf, Dirk, Koornstra, Rutger, Hernandez-Aya, Leonel, Di Giacomo, Anna Maria, van den Eertwegh, Alfonsus J. M., Grob, Jean-Jacques, Gutzmer, Ralf, Jamal, Rahima, Lorigan, Paul C., Krepler, Clemens, Ibrahim, Nageatte, Marreaud, Sandrine, van Akkooi, Alexander, Robert, Caroline, Suciu, Stefan

Get full text Get full text Get full text

Melanoma recurrence patterns and management after adjuvant targeted therapy: a multicentre analysis by Bhave, Prachi, Pallan, Lalit, Long, Georgina V., Menzies, Alexander M., Atkinson, Victoria, Cohen, Justine V., Sullivan, Ryan J., Chiarion-Sileni, Vanna, Nyakas, Marta, Kahler, Katharina, Hauschild, Axel, Plummer, Ruth, Trojaniello, Claudia, Ascierto, Paolo A., Zimmer, Lisa, Schadendorf, Dirk, Allayous, Clara, Lebbe, Celeste, Maurichi, Andrea, Santinami, Mario, Roy, Severine, Robert, Caroline, Lesimple, Thierry, Patel, Sapna, Versluis, Judith M., Blank, Christian U., Khattak, Adnan, Van der Westhuizen, Andre, Carlino, Matteo S., Shackleton, Mark, Haydon, Andrew

Get full text Get full text Get full text

Longer Follow-Up Confirms Recurrence-Free Survival Benefit of Adjuvant Pembrolizumab in High-Risk Stage III Melanoma: Updated Results From the EORTC 1325-MG/KEYNOTE-054 Trial by Eggermont, Alexander M. M., Blank, Christian U., Mandala, Mario, Long, Georgina V., Atkinson, Victoria G., Dalle, Stéphane, Haydon, Andrew M., Meshcheryakov, Andrey, Khattak, Adnan, Carlino, Matteo S., Sandhu, Shahneen, Larkin, James, Puig, Susana, Ascierto, Paolo A., Rutkowski, Piotr, Schadendorf, Dirk, Koornstra, Rutger, Hernandez-Aya, Leonel, Di Giacomo, Anna Maria, van den Eertwegh, Alfonsus J. M., Grob, Jean-Jacques, Gutzmer, Ralf, Jamal, Rahima, Lorigan, Paul C., van Akkooi, Alexander C. J., Krepler, Clemens, Ibrahim, Nageatte, Marreaud, Sandrine, Kicinski, Michal, Suciu, Stefan, Robert, Caroline

Get full text Get full text Get full text

Efficacy of anti-PD-1 and ipilimumab alone or in combination in acral melanoma by Bhave, Prachi, Ahmed, Tasnia, Lo, Serigne N, Shoushtari, Alexander, Zaremba, Anne, Versluis, Judith M, Mangana, Joanna, Weichenthal, Michael, Si, Lu, Lesimple, Thierry, Robert, Caroline, Trojanello, Claudia, Wicky, Alexandre, Heywood, Richard, Tran, Lena, Batty, Kathleen, Dimitriou, Florentia, Stansfeld, Anna, Allayous, Clara, Schwarze, Julia K, Mooradian, Meghan J, Klein, Oliver, Mehmi, Inderjit, Roberts-Thomson, Rachel, Maurichi, Andrea, Yeoh, Hui-Ling, Khattak, Adnan, Zimmer, Lisa, Blank, Christian U, Ramelyte, Egle, Kähler, Katharina C, Roy, Severine, Ascierto, Paolo A, Michielin, Olivier, Lorigan, Paul C, Johnson, Douglas B, Plummer, Ruth, Lebbe, Celeste, Neyns, Bart, Sullivan, Ryan, Hamid, Omid, Santinami, Mario, McArthur, Grant A, Haydon, Andrew M, Long, Georgina V, Menzies, Alexander M, Carlino, Matteo S

Get full text Get full text Get full text